Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
The Review of Scientific Instruments
|
August 1, 2024
Design of a multichannel vacuum ultraviolet spectroscopy system for SPARC
I Song, M L Reinke, J L Raimond, et al.
European Annals of Allergy and Clinical Immunology
|
May 27, 2005
Sublingual specific immunotherapy reduces PBMC proliferations
D Fenoglio, F Puppo, I Cirillo, et al.
The American Journal of Tropical Medicine and Hygiene
|
February 1, 1994
Human papillomavirus and cervical cancer in Honduran women
W Melchers, A Ferrera, D Willemse, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 10, 2008
Sublingual immunotherapy provides an early increase of interferon-gamma production
G Ciprandi, D Fenoglio, M Di Gioacchino, et al.
British Journal of Cancer
|
July 2, 1998
Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines
R E Favoni, A de Cupis, S Bruno, et al.
International Journal of Epidemiology
|
October 18, 2000
Co-factors related to the causal relationship between human papillomavirus and invasive cervical cancer in Honduras
A Ferrera, J P Velema, M Figueroa, et al.
International Journal of Cancer
|
August 14, 1999
Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: a case-control study
A Ferrera, J P Velema, M Figueroa, et al.
Cancer Causes & Control : CCC
|
August 18, 2009
Human papillomavirus infection in Honduran women with normal cytology
N Tábora, J M J E Bakkers, W G V Quint, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2005
Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer
Ali O Gure, Ramon Chua, Barbara Williamson, et al.
Clinical and Vaccine Immunology : CVI
|
November 16, 2007
Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults
P Durando, D Fenoglio, A Boschini, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
The Review of Scientific Instruments
|
August 1, 2024
Design of a multichannel vacuum ultraviolet spectroscopy system for SPARC
I Song, M L Reinke, J L Raimond, et al.
European Annals of Allergy and Clinical Immunology
|
May 27, 2005
Sublingual specific immunotherapy reduces PBMC proliferations
D Fenoglio, F Puppo, I Cirillo, et al.
The American Journal of Tropical Medicine and Hygiene
|
February 1, 1994
Human papillomavirus and cervical cancer in Honduran women
W Melchers, A Ferrera, D Willemse, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 10, 2008
Sublingual immunotherapy provides an early increase of interferon-gamma production
G Ciprandi, D Fenoglio, M Di Gioacchino, et al.
British Journal of Cancer
|
July 2, 1998
Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines
R E Favoni, A de Cupis, S Bruno, et al.
International Journal of Epidemiology
|
October 18, 2000
Co-factors related to the causal relationship between human papillomavirus and invasive cervical cancer in Honduras
A Ferrera, J P Velema, M Figueroa, et al.
International Journal of Cancer
|
August 14, 1999
Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: a case-control study
A Ferrera, J P Velema, M Figueroa, et al.
Cancer Causes & Control : CCC
|
August 18, 2009
Human papillomavirus infection in Honduran women with normal cytology
N Tábora, J M J E Bakkers, W G V Quint, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2005
Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer
Ali O Gure, Ramon Chua, Barbara Williamson, et al.
Clinical and Vaccine Immunology : CVI
|
November 16, 2007
Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults
P Durando, D Fenoglio, A Boschini, et al.
Page
of 3